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LETTERS TO THE EDITORIlluminating Potential Technical
Artifacts of DNA-Methylation
Array ProbesTo the Editor: Recently, Numata et al.1 provided evidence
of changes in DNA methylation in the human prefrontal
cortex (PFC) through human development and aging.
This study reported on three aspects of DNA methylation
in 108 fetal, child, and adult PFC samples with the use of
the Illumina Infinium HumanMethylation27 BeadChip
array. These three aspects were (1) temporal changes in
DNA methylation, (2) genetic polymorphisms in associa-
tion with DNA methylation, and (3) a correlation between
mRNA expression and DNA methylation. Significant age-
and sex-associated changes in DNA methylation were
observedatparticular loci and specifically in regionsoutside
of CpG islands. Although this study is unique in that it
investigates human DNA methylation in a tissue that is
difficult to obtain, there are several technical limitations
thatneed tobe consideredwhen interpreting the arraydata.
Studies examining the relationship between funda-
mental sample characteristics (including age, sex, and
tissue type) and DNA methylation are invaluable as epige-
netic investigations permeate many fields of biology.
Illumina has been a leader in large-scale epigenetic quanti-
fication—it has produced the GoldenGate Methylation
array, its successor, the Infinium HumanMethylation27
BeadChip array, and, most recently, the Infinium Human-
Methylation450 BeadChip array. However, with the expo-
nential increase in genomic coverage comes much greater
complexity to the analysis and interpretation of DNA-
methylation microarray data.Table 1. Top Ten Autosomal CpG Loci with Sex Differences in DNA M
CpG Locus
Target
Chromosome Gene
MIM
Number
DNA
Diff
cg15915418 9 TLE1 600189 fema
cg07711515 9 BAG1 601497 fema
cg27063525 6 C6orf68 610463 fema
cg11673803 10 GLUD1 138130 fema
cg21243096 1 POU3F1 602479 fema
cg04455759 11 SDHD 602690 fema
cg08284151 12 DPPA3 608408 fema
cg05924191 15 FLJ20582 N/A fema
cg23758485 16 SMPD3 605777 fema
cg07494248 2 HSPD1 118190 fema
Adapted from Numata et al., 2012. Affinity is based on theoretical base-pair mat
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that hybridize to complementary genomic sequences and
target specific CpG loci throughout the genome.2 These
probes are cloned and incorporated into beads so that
any given CpG is interrogated several thousand times.
Despite the possible 1.27 3 1030 unique 50 bp sequences,
array design is limited to the specific genomic sequences
surrounding the CpG site of interest. As a result, the
Illumina 27K array is peppered with probes that map to
multiple genomic loci, and it is unlikely that signals from
these cross-hybridizing probes are exclusively from the
intended target CpG. Chen et al.3 characterized nonspe-
cific probes on the Illumina 27K array and found that
about 6%–10% of probes mapped to more than one loca-
tion on the basis of ‘‘90% identity, 40–50 matching bases,
end-nucleotide match, and gapless sequence alignment.’’
The majority of these nonspecific probes were designed
to target autosomal loci that are in repetitive elements or
pseudogenes and thus cross-hybridized to other locations.
Specifically, considering X-autosome cross-hybridizing
probes is important because of the chromosomal imbal-
ance between sexes.
Chen et al. suggest that autosomal sex-specific DNA-
methylation differences identified on the Illumina 27K
array might be artifacts of probes that cross-hybridize to
the X chromosome. Seven of the ten sexually dimorphic
target CpGs identified by Numata et al. were reported to
cross-hybridize to the X chromosome.3 We BLASTed the
autosomal sexually dimorphic target CpGs identified by
Numata et al., and we note the location and affinity of sus-
pected cross-hybridization in Table 1. Six of these probes
cross-hybridized to X chromosome CpG-island promoters.
At these CpGs, females were reported as hypermethylated
in comparison to males, which is consistent with theethylation
Methylation
erence
Cross-hybridization
Chromosome Affinity
le > male X 98%
le < male X 100%
le > male X 100%
le > male X 100%
le > male 2, X 100%, 50% (100% last 25 bp)
le < male X 94%
le > male 14, X 98%, 96%
le > male X 96%
le > male none 
le > male none 
ching by BLAST. The following abbreviation is used: N/A, not available.
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Table 2. Top Ten Most Significant CpG-trans-SNP Associations
CpG Locus Gene
MIM
Number SNP
SNP
Chromosome
Cross-hybridization
Chromosome Affinity Distance to SNP
cg18984499 RPL26 603704 rs11847580 14 14 84% 13.3 kb
cg17704839 UBL5 606849 rs733675 17 17 78% 26.6 kb
cg18634211 LIN28 611043 rs2288322 2 2 70% 0.8 kb
cg18634211 LIN28 611043 rs10207436 2 2 70% 27.6 kb
cg25299176 YWHAE 605066 rs4281963 2 2 92% 10.2 kb
cg03923277 TDG 601423 rs326387 12 none  214.9 kb
cg2599176 YWHAE 605066 rs6716175 2 2 92% 36.1 kb
cg18984499 RPL26 603704 rs4906142 14 14 84% 94.4 kb
cg13514129 MACF1 608271 rs12130070 1 none  205 Mb
cg13514129 MACF1 608271 rs2878079 1 none  205 Mb
Adapted from Numata et al., 2012. Affinity is based on theoretical base-pair matching by BLAST.general hypermethylation of CpG-island promoters on the
inactive X chromosome.4 For two probes, females were
observed to be hypomethylated in comparison to males.
Both of these probes cross-hybridized to the X chromo-
some; one was in a gene body, and the other was in
a non-CpG-island intergenic region. These regions are
often hypermethylated on the active X chromosome
compared to the inactive X chromosome. The fact that
males only possess an active X chromosome most likely
accounts for the hypermethylated state of males at these
two CpGs.5 Therefore, the top eight target CpGs identified
by Numata et al. to have sexually dimorphic DNA methyl-
ation are most likely technical artifacts due to X chromo-
some cross-hybridization.
Numata et al. identified close to 3,000 correlations
between DNA methylation and the presence of a SNP
within 1 Mb of the target CpG (such a SNP is termed
a cis-SNP), demonstrating that genotype and DNAmethyl-
ation are associated in many instances. The closer the SNP
to the CpG of interest, the greater the association. This
pattern holds true for other genomic operators, including
enhancers and insulators,6 which are more likely to affect
closer targets. Numata et al. also identified 401 trans-SNPs
(>1Mb from the target CpG) associated with DNAmethyl-
ation. BLASTing the probe sequence of the top ten CpGs
associated with a trans-SNP, we noted that seven of these
cross-hybridize to other genomic locations, all of which
are located within 100 kb of the SNP (Table 2). It is there-
fore likely that the strong trans-SNP-CpG associations
were influenced by cis-SNP-CpG associations at the locus
of cross-hybridization.
Although there are probably sex differences in DNA
methylation at some loci on autosomal chromosomes, in
addition to trans-SNPs that are associated with DNA meth-
ylation, the true number is probably lower than what was
initially reported by Numata et al. This is one of several
studies that have not omitted cross-hybridizing probes.7,8The AmericOther probes, such as those with a SNP in the target
CpG, should also be scrutinized because they might alter
assessment of DNA methylation. With the advent of
Illumina’s Infinium HumanMethylation450 array, which
carries almost 20 times more probes than the Infinium
HumanMethylation27 does, there is a far greater potential
for probe-related technical artifacts. Given the popularity
of the Illumina bead platform, it is important for all
users to be aware of these complications. For methyla-
tion arrays, we suggest BLASTing candidate CpGs for
identifying cross-hybridizing probes with the use of
Chen et al.’s conservative criteria. By raising awareness of
the complexities of using DNA-methylation microarrays,
we hope to increase the likelihood of reporting true bio-
logical findings.
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Web Resources
The URLs for data presented herein are as follows:
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Online Mendelian Inheritance in Man (OMIM), http://omim.org
References
1. Numata, S., Ye, T., Hyde, T.M., Guitart-Navarro, X., Tao, R.,
Wininger, M., Colantuoni, C., Weinberger, D.R., Kleinman,
J.E., and Lipska, B.K. (2012). DNA methylation signatures in
development and aging of the human prefrontal cortex. Am.
J. Hum. Genet. 90, 260–272.an Journal of Human Genetics 91, 760–764, October 5, 2012 761
2. Bibikova, M., Le, J., Barnes, B., Saedinia-Melnyk, S., Zhou, L.,
Shen, R., and Gunderson, K.L. (2009). Genome-wide DNA
methylation profiling using Infinium assay. Epigenomics 1,
177–200.
3. Chen, Y.A., Choufani, S., Ferreira, J.C., Grafodatskaya, D.,
Butcher, D.T., and Weksberg, R. (2011). Sequence overlap
between autosomal and sex-linked probes on the Illumina
HumanMethylation27 microarray. Genomics 97, 214–222.
4. Cotton, A.M., Lam, L., Affleck, J.G., Wilson, I.M., Pen˜aherrera,
M.S., McFadden, D.E., Kobor, M.S., Lam, W.L., Robinson, W.P.,
and Brown, C.J. (2011). Chromosome-wide DNA methylation
analysis predicts human tissue-specific X inactivation. Hum.
Genet. 130, 187–201.
5. Hellman, A., and Chess, A. (2007). Gene body-specific methyl-
ation on the active X chromosome. Science 315, 1141–1143.
6. Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo´, R.,
Gingeras, T.R., Margulies, E.H., Weng, Z., Snyder, M., Dermitza-
kis, E.T., Thurman, R.E., et al; ENCODE Project Consortium,762 The American Journal of Human Genetics 91, 760–764, OctoberNISC Comparative Sequencing Program, Baylor College of
Medicine Human Genome Sequencing Center, Washington
University Genome Sequencing Center, Broad Institute,
Children’s Hospital Oakland Research Institute. (2007). Identi-
fication and analysis of functional elements in 1% of the
human genome by the ENCODE pilot project. Nature 447,
799–816.
7. Gibbs, J.R., van der Brug, M.P., Hernandez, D.G., Traynor, B.J.,
Nalls, M.A., Lai, S.L., Arepalli, S., Dillman, A., Rafferty, I.P.,
Troncoso, J., et al. (2010). Abundant quantitative trait loci exist
for DNA methylation and gene expression in human brain.
PLoS Genet. 6, e1000952.
8. Liu, J., Morgan, M., Hutchison, K., and Calhoun, V.D. (2010).
A study of the influence of sex on genome wide methylation.
PLoS ONE 5, e10028.http://dx.doi.org/10.1016/j.ajhg.2012.05.028. 2012 by The American
Society of Human Genetics. All rights reserved.Cross-Reactive DNA Microarray
Probes Lead to False Discovery of
Autosomal Sex-Associated DNA
MethylationTo the Editor: The majority of the significant sex-associ-
ated DNA-methylation sites at autosomal CpG loci re-
ported by Numata et al.1 do not reflect a true biological
phenomenon. Rather, the conclusions in this paper reflect
a technical artifact created by the presence of cross-reactive
autosomal probes hybridizing to both autosomal and sex
chromosomes.
Numata et al.1 used the Illumina Infinium HumanMe-
thylation27K microarray to assess genome-wide DNA
methylation. This microarray uses 50 nt probes to target
27,578 CpG sites covering ~13,000 genes. So that one
can distinguish between the methylated and unmethy-
lated alleles, DNA is treated with sodium bisulfite for con-
verting unmethylated cytosines to uracil. Then, PCR
amplification converts uracil to thymidine. In contrast,
methylated cytosines remain cytosines. In this microarray,
two probes are designed for each CpG site—one is designed
for the methylated allele (cytosine), and the other is de-
signed for the unmethylated allele (thymidine).
On the Illumina Infinium HumanMethylation27K mi-
croarray, there is a subset of probes that target autosomal
loci but cross-react with genomic regions on the sex chro-
mosomes. Because one of the X chromosomes in females
is heavily methylated as a result of X inactivation,2 auto-
somal CpG loci targeted by probes that overlap these
heavily methylated loci create spurious signals and there-
fore appear more methylated in females than in males.On the other hand, autosomal probes cross-hybridizing to
unmethylated X chromosome loci that escape X inactiva-
tion show lower methylation in females than in males.
Likewise for theY chromosome, probes that cross-hybridize
also shift the DNA-methylation level of the originally tar-
geted autosomal CpG loci to produce a spurious increase
in the methylation signals in males compared to females.
We can identify cross-reactive probes on the 27K micro-
array as having highly identical matches to nontargeted
loci by first mapping probe sequences against the
in silico sodium-bisulfite-converted reference genome
(hg18) by using BLAT.3 In addition, the end nucleotide of
the probes and the nontargeted loci are required to be
the same for cross-hybridization to occur because array
signals are derived from single-base extension of fluores-
cently tagged nucleotides at one end of the probes that
correspond to the targeted CpGs. In Table 1, we have ap-
pended the potential cross-hybridizing targets of probes
corresponding to the top ten autosomal genes described
by Numata et al.1 as having the most significant sex differ-
ences. Using the same microarray platform, Liu et al. and
Adkins et al.4–6 also reported the same overlapping set of
autosomal sex-associated DNA-methylation sites, which
we have found to be the result of technical artifact.3 The
claim by Numata et al.1 that 5% of autosomal loci (or
1,333 CpGs) have significant differential methylation asso-
ciated with sex is likely to be an overestimate because of
the presence of autosomal probes cross-hybridizing to
the sex chromosomes. The full list of CpG sites proposed
to have significant sex differences was not published, so
they could not be evaluated. Of course, this does not
exclude the possibility that there are indeed true auto-
somal sex-associated sites of DNA methylation in humans
because two of the top ten autosomal sex-associated
CpG sites reported by Numata et al.1 are not targeted by5, 2012
